Kentucky All Schedule Prescription Electronic Reporting (KASPER): A General Overview

Faculty

Needs Statement

There is a need for healthcare professionals in Kentucky to deepen their understanding and usage of the KASPER system due to the growing complexities of prescription drug regulations and the necessity to manage at-risk patients effectively. This training aims to enhance familiarity with KASPER’s framework, improve proficiency in navigating its tools, and strengthen the ability to interpret relevant data and DEA responsibilities. By addressing these needs, this presentation will empower healthcare providers to better comply with legal standards and enhance patient care within the scope of prescription drug monitoring.

Target Audience

The target audience for this course includes physicians, advanced practice providers, pharmacists, nurses, and any other individuals who participate in the prevention and treatment of substance use disorders and sustained recovery.

Objectives

Upon completion of the educational activity, participants will be able to:

1. Understand KASPER's Framework and Regulatory Environment:
• Explain the purpose and composition of KASPER.
• Identify and locate relevant Kentucky regulations and statutes.
• Describe the data reported to KASPER, including exclusions.
2. Learn KASPER Tools and Usage:
• Navigate the Kentucky Online Gateway/KASPER Portal effectively.
• Apply critical tools such as the Reverse KASPER Report and Prescriber Report Card.
• Apply clinical judgment to intervene with at-risk patients.
3. Understand Relevant KASPER Data and Interpret DEA Responsibilities:
• Gain insights into KASPER Integration and Interstate Data Sharing initiatives.
• Interpret DEA responsibilities and the KASPER Quarterly Trend Report.
• Familiarize with relevant statistics concerning Kentucky.

Accreditation

In support of improving patient care, this activity has been planned and implemented by UK HealthCare CECentral and Kentucky Office of Inspector General (OS). University of Kentucky HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CME
This enduring material is designated for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

This training has been approved by the KBML as meeting the statutory requirements of HB1. 0824-H1.0-UKCE4dd

IPE Competencies

• Roles/ Responsibilities
• Interprofessional Communication

CPE
This knowledge-based activity will award 1.00 contact hour (0.100 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.

Other
UK Healthcare CECentral certifies this activity for 1.00 hour of participation.

CNE
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.00 nursing contact hour.

AMA PRA Category 1 CME for ABS MOC II (Surgery)
This enduring material is designated for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Surgery's Continuous Certification program. It is UK HealthCare CECentral's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit. Surgeons completing this course receive 1.00 CME-HB1 continuing education credit

This training has been approved by the KBML as meeting the statutory requirements of HB1. 0824-H1.0-UKCE4dd

IPE Competencies

• Roles/ Responsibilities
• Interprofessional Communication

Faculty Disclosure

All planners, faculty, and others in control of educational content are required to disclose all their financial relationships with ineligible companies within the prior 24 months.  An ineligible company is defined as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company. 

None of the planners, faculty, and others in control of educational content for this educational activity have a relevant financial relationship(s) to disclose with ineligible companies.

The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.

Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Acknowledgement

This activity is jointly provided by the University of Kentucky and Kentucky Office of Inspector General (OS).

In collaboration with Kentucky Injury Prevention and Research Center (KIPRC).